{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:40:49Z","timestamp":1772656849243,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ctim.2025.103165","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T11:02:57Z","timestamp":1742641377000},"page":"103165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pharmacokinetic interactions of fruit juices with antihypertensive drugs in humans: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-8769","authenticated-orcid":false,"given":"Janthima","family":"Methaneethorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyameth","family":"Dilokthornsakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tippawan","family":"Siritientong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanaporn","family":"Chareonchokthavee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattawut","family":"Leelakanok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"10304","key":"10.1016\/j.ctim.2025.103165_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2025.103165_bib3","series-title":"Encyclopedia of Heart Diseases","first-page":"538","article-title":"Hypertension","year":"2011"},{"issue":"18","key":"10.1016\/j.ctim.2025.103165_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib5","article-title":"Role of dietary components in modulating hypertension","volume":"7","author":"Feyh","year":"2016","journal-title":"J Clin Exp Cardiol"},{"issue":"9","key":"10.1016\/j.ctim.2025.103165_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/75.9.933","article-title":"Drug\u2013grapefruit juice interactions","volume":"75","author":"Kane","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ajcn\/85.3.895","article-title":"Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women","volume":"85","author":"Mink","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3945\/jn.110.133843","article-title":"Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women","volume":"141","author":"Landberg","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.ctim.2025.103165_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.907595","article-title":"Grapefruit juice flavanones modulate the expression of genes regulating inflammation, cell interactions and vascular function in peripheral blood mononuclear cells of postmenopausal women","volume":"9","author":"Krga","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/01635589609514473","article-title":"Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices","volume":"26","author":"So","year":"1996","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib11","first-page":"98","article-title":"Effects of Citrus sinensis juice on blood pressure","volume":"9","author":"Asgary","year":"2013","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.ctim.2025.103165_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2016.11.018","article-title":"Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"115","author":"Sahebkar","year":"2017","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.ctim.2025.103165_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082618","article-title":"Effects of cranberry juice supplementation on cardiovascular disease risk factors in adults with elevated blood pressure: a randomized controlled trial","volume":"13","author":"Richter","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/foods10010033","article-title":"Food-drug interactions with fruit juices","volume":"10","author":"Petric","year":"2020","journal-title":"Foods"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0091270004265367","article-title":"Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?","volume":"44","author":"Huang","year":"2004","journal-title":"J Clin Pharm"},{"issue":"7","key":"10.1016\/j.ctim.2025.103165_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.bjp.0706008","article-title":"Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux","volume":"143","author":"Honda","year":"2004","journal-title":"Br J Pharm"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/17425255.2011.553189","article-title":"The effect of grapefruit juice on drug disposition","volume":"7","author":"Hanley","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ctim.2025.103165_bib18","first-page":"313","article-title":"Studies of food drug interactions","volume":"23","author":"Faisal","year":"2010","journal-title":"Pak J Pharm Sci"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib19","first-page":"135","article-title":"Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation","volume":"40","author":"Bailey","year":"1995","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"10.1016\/j.ctim.2025.103165_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00192360","article-title":"Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects","volume":"49","author":"Lundahl","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1016022827235","article-title":"Effects on the pharmacokinetics and pharmacodynamics in the elderly of coadministering ramipril with water, apple juice, and applesauce","volume":"13","author":"Lee","year":"1996","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib22","first-page":"233","article-title":"Grapefruit juice does not alter the pharmacokinetics of amlodipine in man","volume":"61","author":"Vincent","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ctim.2025.103165_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0011-393X(98)85060-1","article-title":"Effects of grapefruit juice on the pharmacokinetics of the calcium channel blockers nifedipine and nisoldipine","volume":"59","author":"Azuma","year":"1998","journal-title":"Curr Ther Res - Clin Exp"},{"issue":"9-10","key":"10.1016\/j.ctim.2025.103165_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s002280000235","article-title":"Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site","volume":"56","author":"Uno","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(98)90173-4","article-title":"Grapefruit juice-felodipine interaction: effect of naringin and 6\u2032,7\u2032- dihydroxybergamottin in humans","volume":"64","author":"Bailey","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mcp.2000.107524","article-title":"Grapefruit juice--felodipine interaction in the elderly","volume":"68","author":"Dresser","year":"2000","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib27","first-page":"99","article-title":"Interactions of grapefruit juice and cardiovascular medications: a potential risk of toxicity","volume":"8","author":"Lim","year":"2003","journal-title":"Exp Clin Cardiol"},{"issue":"9","key":"10.1016\/j.ctim.2025.103165_bib28","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2174\/138920112800958878","article-title":"Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions","volume":"13","author":"Uesawa","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ctim.2025.103165_bib29","article-title":"ROB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2025.103165_bib30","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"29","key":"10.1016\/j.ctim.2025.103165_bib31","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.ctim.2025.103165_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.ctim.2025.103165_bib33","unstructured":"Deeks J.J.H.J., Altman D.G. (eds.). Chapter 10: analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds.). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). The Cochrane Collaboration; 2022. Available from: (http:\/\/www.training.cochrane.org\/handbook). Cochrane handbook for systematic reviews of interventions version 6.3: The Cochrane Collaboration; 2022."},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/138920007781368917","article-title":"Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine","volume":"8","author":"Guo","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ajcn\/83.5.1097","article-title":"A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction","volume":"83","author":"Paine","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clpt.2004.02.007","article-title":"6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect","volume":"75","author":"Kakar","year":"2004","journal-title":"Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9236(03)00051-1","article-title":"Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice","volume":"73","author":"Bailey","year":"2003","journal-title":"Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1067\/mcp.2000.110774","article-title":"Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients","volume":"68","author":"Bailey","year":"2000","journal-title":"Clin Pharm Ther"},{"issue":"10","key":"10.1016\/j.ctim.2025.103165_bib39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI119439","article-title":"Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression","volume":"99","author":"Lown","year":"1997","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/clpt.1993.84","article-title":"Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin","volume":"53","author":"Bailey","year":"1993","journal-title":"Clin Pharm Ther"},{"issue":"8736","key":"10.1016\/j.ctim.2025.103165_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(91)90872-M","article-title":"Interaction of citrus juices with felodipine and nifedipine","volume":"337","author":"Bailey","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2710.2004.00618.x","article-title":"Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms","volume":"30","author":"Odou","year":"2005","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1995.tb04534.x","article-title":"Factors affecting the absolute bioavailability of nifedipine","volume":"40","author":"Rashid","year":"1995","journal-title":"Br J Clin Pharm"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002280050470","article-title":"The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil","volume":"54","author":"Zaidenstein","year":"1998","journal-title":"Eur J Clin Pharm"},{"key":"10.1016\/j.ctim.2025.103165_bib45","unstructured":"FDA. Guidance for industry: food-effect bioavailability and fed bioequivalence studies. 2002 (http:\/\/www.fda.gov\/files\/drugs\/published\/Food-Effect-Bioavailability-and-Fed-BioequivalenceStudies.pdf). Accessed November 1, 2024."},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/clpt.2010.101","article-title":"Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren","volume":"88","author":"Tapaninen","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1365-2125.2010.03898.x","article-title":"Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren","volume":"71","author":"Tapaninen","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00228-011-1167-4","article-title":"Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects","volume":"68","author":"Rebello","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007691-200108000-00008","article-title":"Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers","volume":"23","author":"Zaidenstein","year":"2001","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00228-011-1106-4","article-title":"Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects","volume":"68","author":"Shoaf","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2125.2005.02489.x","article-title":"Effects of grapefruit juice on the pharmacokinetics of acebutolol","volume":"60","author":"Lilja","year":"2005","journal-title":"Br J Clin Pharm"},{"issue":"5-6","key":"10.1016\/j.ctim.2025.103165_bib52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00228-005-0930-9","article-title":"Effects of orange juice on the pharmacokinetics of atenolol","volume":"61","author":"Lilja","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2012.04324.x","article-title":"Apple juice greatly reduces systemic exposure to atenolol","volume":"75","author":"Jeon","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1067\/mcp.2003.26","article-title":"Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol","volume":"73","author":"Lilja","year":"2003","journal-title":"Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clpt.2003.11.002","article-title":"Orange juice substantially reduces the bioavailability of the \u03b2-adrenergic-blocking agent celiprolol","volume":"75","author":"Lilja","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ctim.2025.103165_bib56","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0091270011408612","article-title":"Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose","volume":"52","author":"Ieiri","year":"2012","journal-title":"J Clin Pharm"},{"issue":"12","key":"10.1016\/j.ctim.2025.103165_bib57","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1248\/bpb.b13-00538","article-title":"Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome P450 3A4","volume":"36","author":"Tanaka","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"10.1016\/j.ctim.2025.103165_bib58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jcph.95","article-title":"Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers","volume":"53","author":"Misaka","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clpt.2004.11.111","article-title":"Grapefruit juice ingestion significantly reduces talinolol bioavailability","volume":"77","author":"Schwarz","year":"2005","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002280050183","article-title":"Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers","volume":"51","author":"Josefsson","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3999\/jscpt.37.3_127","article-title":"Effect of a single glass of grapefruit juice on the apparent oral bioavailability of the dihydropyridine calcium channel antagonist, azelnidipine, in healthy Japanese volunteers","volume":"37","author":"Hirashima","year":"2006","journal-title":"Jpn J Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ctim.2025.103165_bib62","first-page":"675","article-title":"Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects","volume":"49","author":"Sigusch","year":"1994","journal-title":"Pharmazie"},{"issue":"8","key":"10.1016\/j.ctim.2025.103165_bib63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00228-002-0516-8","article-title":"Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers","volume":"58","author":"Christensen","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ctim.2025.103165_bib64","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5414\/CPP46511","article-title":"Influence of grape juice and orange juice on the pharmacokinetics and pharmacodynamics of diltiazem in healthy human male subjects","volume":"46","author":"Ahmed","year":"2008","journal-title":"Int J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00266354","article-title":"Regrdh CG. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine - and its potential clinical relevance","volume":"42","author":"Edgar","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"issue":"1-2","key":"10.1016\/j.ctim.2025.103165_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00192360","article-title":"Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects","volume":"49","author":"Lundahl","year":"1995","journal-title":"Eur J Clin Pharm"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-9236(96)90163-0","article-title":"Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice","volume":"60","author":"Bailey","year":"1996","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002280050263","article-title":"Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men","volume":"52","author":"Lundahl","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002280050424","article-title":"The interaction effect of grapefruit juice is maximal after the first glass","volume":"54","author":"Lundahl","year":"1998","journal-title":"Eur J Clin Pharm"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1067\/mcp.2001.113185","article-title":"Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins","volume":"69","author":"Malhotra","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib71","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clpt.2004.08.019","article-title":"Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans","volume":"76","author":"Goosen","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/138920007781368917","article-title":"Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine","volume":"8","author":"Guo","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib73","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2125.2006.02583.x","article-title":"Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects","volume":"61","author":"Uno","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.1993.195","article-title":"Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics","volume":"54","author":"Bailey","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1067\/mcp.2000.104215","article-title":"Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects","volume":"67","author":"Takanaga","year":"2000","journal-title":"Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib76","first-page":"126","article-title":"Grapefruit juice increases oral nimodipine bioavailability","volume":"36","author":"Fuhr","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"9-10","key":"10.1016\/j.ctim.2025.103165_bib77","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s002280050547","article-title":"Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects","volume":"54","author":"Hashimoto","year":"1998","journal-title":"Eur J Clin Pharm"},{"issue":"9-10","key":"10.1016\/j.ctim.2025.103165_bib78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s002280000189","article-title":"Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers","volume":"56","author":"Ho","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00228-002-0436-7","article-title":"Effects of grapefruit juice and smoking on verapamil concentrations in steady state","volume":"58","author":"Fuhr","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/dmd.104.002337","article-title":"Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B","volume":"33","author":"Satoh","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.ctim.2025.103165_bib81","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.clpt.6100104","article-title":"Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice","volume":"81","author":"Bailey","year":"2007","journal-title":"Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2891-6-33","article-title":"Medicinal importance of grapefruit juice and its interaction with various drugs","volume":"6","author":"Kiani","year":"2007","journal-title":"Nutr J"},{"issue":"11","key":"10.1016\/j.ctim.2025.103165_bib83","doi-asserted-by":"crossref","first-page":"e1323","DOI":"10.4088\/JCP.14f09572","article-title":"Fruit juice, organic anion transporting polypeptides, and drug interactions in psychiatry","volume":"75","author":"Andrade","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.ctim.2025.103165_bib84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003088-200847080-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of aliskiren","volume":"47","author":"Vaidyanathan","year":"2008","journal-title":"Clin Pharm"},{"issue":"11","key":"10.1016\/j.ctim.2025.103165_bib85","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/0091270008323258","article-title":"Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren","volume":"48","author":"Vaidyanathan","year":"2008","journal-title":"J Clin Pharm"},{"issue":"9","key":"10.1016\/j.ctim.2025.103165_bib86","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.xphs.2017.04.004","article-title":"Intestinal drug interactions mediated by OATPs: a systematic review of preclinical and clinical findings","volume":"106","author":"Yu","year":"2017","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.ctim.2025.103165_bib87","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharm"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib88","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s13318-020-00634-4","article-title":"Potential risk of food-drug interactions: citrus polymethoxyflavones and flavanones as inhibitors of the organic anion transporting polypeptides (OATP) 1B1, 1B3, and 2B1","volume":"45","author":"Bajraktari-Sylejmani","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.ctim.2025.103165_bib89","first-page":"123","article-title":"Angiotensin II receptor blockers","volume":"16","author":"Barreras","year":"2003","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib90","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0009-9236(95)90020-9","article-title":"Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans","volume":"58","author":"Lo","year":"1995","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.ctim.2025.103165_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0090-9556(25)06520-1","article-title":"Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members","volume":"23","author":"Stearns","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.ctim.2025.103165_bib92","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjhyper.2005.11.003","article-title":"Interaction of grapefruit juice and calcium channel blockers","volume":"19","author":"Sica","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ctim.2025.103165_bib93","unstructured":"Nisoldipine. DrugBank Online. Available at: \u3008https:\/\/go.drugbank.com\/drugs\/DB00401\u3009. Accessed December 4."},{"key":"10.1016\/j.ctim.2025.103165_bib94","unstructured":"Felodipine. DrugBank Online. Available at: \u3008https:\/\/go.drugbank.com\/drugs\/DB01023\u3009. Accessed December 4."},{"key":"10.1016\/j.ctim.2025.103165_bib95","unstructured":"Nifedipine. DrugBank Online. Available at: \u3008https:\/\/go.drugbank.com\/drugs\/DB01115\u3009. Accessed December 4."},{"key":"10.1016\/j.ctim.2025.103165_bib96","unstructured":"Amlodipine. DrugBank Online. Available at: \u3008https:\/\/go.drugbank.com\/drugs\/DB00381\u3009. Accessed December 4."},{"issue":"6","key":"10.1016\/j.ctim.2025.103165_bib97","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0090-9556(25)08440-5","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug Metab Dispos"},{"issue":"1-2","key":"10.1016\/j.ctim.2025.103165_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.12.004","article-title":"Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits","volume":"297","author":"Choi","year":"2005","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.ctim.2025.103165_bib99","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2125.1999.00923.x","article-title":"Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil","volume":"47","author":"Tracy","year":"1999","journal-title":"Br J Clin Pharm"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229925000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229925000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:28:35Z","timestamp":1745375315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229925000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":99,"alternative-id":["S0965229925000408"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2025.103165","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic interactions of fruit juices with antihypertensive drugs in humans: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2025.103165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103165"}}